Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Moderna Rises As Vaccine Found 100% Effective In Teens

Published 2021-05-25, 09:08 a/m
Updated 2021-05-25, 09:08 a/m
©  Reuters

© Reuters

 By Dhirendra Tripathi

Investing – Moderna (NASDAQ:MRNA) shares rose nearly 3% in Tuesday’s premarket trading as the company said its Covid-19 vaccine has been found to be 100% effective in teenagers and that it would seek regulatory approval next month for its emergency use in that age group.

Moderna conducted trials among adolescents aged 12 to less than 18 years. The findings make its vaccine second behind Pfizer’s to demonstrate high efficacy in younger people. Children make up close to 20% of the U.S. population, per government data.

The company, which uses mRNA technology to make its Covid-19 shots, said no cases of the viral infection were observed after two doses of vaccine using the primary case definition, consistent with a vaccine efficacy of 100%.

The majority of adverse events were mild or moderate in severity, the company said in a release.

All participants will be monitored for 12 months after their second injection to assess long-term protection and safety, it said.

If approved, the vaccine will be a great morale booster for parents and help to bring their children back to schools this fall.

The two-dose vaccine is already authorized for adults and has helped to tame the virus in the U.S, along with Pfizer (NYSE:PFE)-BioNTech's (NASDAQ:BNTX) shot.

Moderna has forecast supplying 800 million to 1 billion doses of its vaccine in 2021 with another 2 billion doses to be supplied in 2021, the production coming from its own and partners’ facilities.

 

 

Latest comments

100% effective at destroying your health
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.